Lack of Motor Symptoms Progression in Parkinson's Disease Patients With Long-Term Bilateral Subthalamic Deep Brain Stimulation

REFERENCES

• Bonnet, A. M., Loria, Y., Saint-Hilaire, M. H., Lhermitte, F., & Agid, Y. (1987). Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology, 37(9), 1539–1542.
   PubMed Web of Science ®Google Scholar
• Defer, G. L., Widner, H., Marié, R. M., Rémy, P., & Levivier, M. (1999). Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Movement Disorders, 14(4), 572–584.
   PubMed Web of Science ®Google Scholar
• Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schafer, H., Botzel, K., (2006). A randomized trial of deep-brain stimulation for Parkinson's disease. The New England Journol of Medicine, 355(9), 896–908.
   PubMed Web of Science ®Google Scholar
• Fahn, S., Oakes, D., Shoulson, I., Kieburtz, K., Rudolph, A., Lang, A., (2004). Levodopa and the progression of Parkinson's disease. The New England Journal of Medicine, 351(24), 2498–508.
   PubMed Web of Science ®Google Scholar
• Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17(5), 427–442.
   PubMed Web of Science ®Google Scholar
• Isaias, I., & Tagliati, M. (2008). Deep brain stimulation programming for movement disorders. In D. Tarsy (ed.), Deep Brain Stimulation in Neurological and Psychiatric Disorders (pp. 361–400). New York: Humana Press.
   Google Scholar
• Kleiner-Fisman, G., Herzog, J., Fisman, D. N., Tamma, F., Lyons, K. E., Pahwa, R., (2006). Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes. Movement Disorder, 21(Suppl 14), S290–S304.
   PubMed Web of Science ®Google Scholar
• Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., (2003). Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. The New England Journal of Medicine, 349(20), 1925–1934.
   PubMed Web of Science ®Google Scholar
• Liang, G. S., Chou, K. L., Baltuch, G. H., Jaggi, J. L., Loveland-Jones, C., Leng, L., (2006). Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease. Stereotactic and Functional Neurosurgery, 84(5–6), 221–227.
   PubMedGoogle Scholar
• Louis, E. D., Tang, M. X., Cote, L., Alfaro, B., Mejia, H., & Marder, K. (1999). Progression of Parkinsonian signs in Parkinson's disease. Archives of Neurology, 56(3), 334–337.
   PubMedGoogle Scholar
• Maesawa, S., Kaneoke, Y., Kajita, Y., Usui, N., Misawa, N., Nakayama, A., (2004). Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: Neuroprotection of dopaminergic neurons. Journal of Neurosurgery, 100(4), 679–687.
   PubMed Web of Science ®Google Scholar
• Montgomery, E. B., Jr., & Gale, J. T. (2008). Mechanisms of action of deep brain stimulation (DBS). Neuroscience and Biobehavioral Reviews, 32(3), 388–407.
   PubMed Web of Science ®Google Scholar
• Ostergaard, K., & Aa Sunde, N. (2006). Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Movement Disorders, 21(5), 624–631.
   PubMed Web of Science ®Google Scholar
• Piboolnurak, P., Lang, A. E., Lozano, A. M., Miyasaki, J. M., Saint-Cyr, J. A., Poon, Y. Y., (2007). Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease. Movement Disorders, 22(7), 990–997.
   PubMed Web of Science ®Google Scholar
• Rodriguez, M. C., Obeso, J. A., & Olanow, C. W. (1998). Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: A target for neuroprotection. Annals of Neurology, 44 (3 Suppl 1), S175–S188.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Oroz, M. C., Obeso, J. A., Lang, A. E., Houeto, J. L., Pollak, P., Rehncrona, S., (2005). Bilateral deep brain stimulation in Parkinson's disease: A multicentre study with 4 years follow-up. Brain, 128 (Pt 10), 2240–2249.
   PubMed Web of Science ®Google Scholar
• Schrag, A., Dodel, R., Spottke, A., Bornschein, B., Siebert, U., & Quinn, N. P. (2007). Rate of clinical progression in Parkinson's disease. A prospective study. Movement Disorders, 22(7), 938–945.
   PubMed Web of Science ®Google Scholar
• Schupbach, W. M., Chastan, N., Welter, M. L., Houeto, J. L., Mesnage, V., Bonnet, A. M., (2005). Stimulation of the subthalamic nucleus in Parkinson's disease: A 5-year follow-up. Journal of Neurology, Neurosurgery, and Psychiatry, 76(12), 1640–1644.
   PubMed Web of Science ®Google Scholar
• Shils, J., Tagliati, M., & Miravite, J. (2002). Differential response of PD symptoms in the subthalamic nucleus during deep brain stimulation. Movement Disorders, 17(Suppl 5), 193.
   Google Scholar
• Temel, Y., Visser-Vandewalle, V., Kaplan, S., Kozan, R., Daemen, M. A., Blokland, A., (2006). Protection of nigral cell death by bilateral subthalamic nucleus stimulation. Brain Reserach, 1120(1), 100–105.
   PubMedGoogle Scholar
• Temperli, P., Ghika, J., Villemure, J. G., Burkhard, P. R., Bogousslavsky, J., & Vingerhoets, F. J. (2003). How do Parkinsonian signs return after discontinuation of subthalamic DBS? Neurology, 60(1), 78–81.
   PubMedGoogle Scholar
• Visser-Vandewalle, V., Van Der Linden, C., Temel, Y., Celik, H., Ackermans, L., Spincemaille, G., (2005). Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: A four-year follow-up study. Parkinsonism & Related Disorders, 11(3), 157–165.
   PubMedGoogle Scholar
• Wallace, B. A., Ashkan, K., Heise, C. E., Foote, K. D., Torres, N., Mitrofanis, J., (2007). Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain, 130(Pt 8), 2129–2145.
   PubMedGoogle Scholar